Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Tax Provisions: 2018-2025

Historic Tax Provisions for Akebia Therapeutics (AKBA) over the last 1 years, with Sep 2025 value amounting to $615,000.

  • Akebia Therapeutics' Tax Provisions was N/A to $615,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year change of. This contributed to the annual value of -$6.6 million for FY2019, which is 76.60% up from last year.
  • According to the latest figures from Q3 2025, Akebia Therapeutics' Tax Provisions is $615,000, which was up 109.32% from -$6.6 million recorded in Q4 2019.
  • In the past 5 years, Akebia Therapeutics' Tax Provisions ranged from a high of $615,000 in Q3 2025 and a low of $615,000 during Q3 2025.
  • Over the past 1 years, Akebia Therapeutics' median Tax Provisions value was $615,000 (recorded in 2025), while the average stood at $615,000.